LTR Pharma Limited (ASX: LTP)
Australia
· Delayed Price · Currency is AUD
1.225
+0.005 (0.41%)
Nov 21, 2024, 2:42 PM AEST
LTR Pharma Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Other Revenue | 0.05 | 0.05 | - | 0.01 | - |
| Revenue | 0.05 | 0.05 | - | 0.01 | - |
| Gross Profit | 0.05 | 0.05 | - | 0.01 | - |
| Selling, General & Admin | 1.65 | 1.65 | 0.59 | 0.68 | 0.03 |
| Research & Development | 3.51 | 3.51 | 0.82 | 0.35 | - |
| Other Operating Expenses | 0.53 | 0.53 | 0.03 | - | - |
| Operating Expenses | 6.99 | 6.99 | 1.44 | 1.03 | 0.03 |
| Operating Income | -6.94 | -6.94 | -1.44 | -1.02 | -0.03 |
| Interest Expense | -0 | -0 | -0 | -0 | -0.01 |
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0 |
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.02 | -0.01 | -0 |
| Pretax Income | -6.95 | -6.95 | -1.45 | -1.03 | -0.04 |
| Net Income | -6.95 | -6.95 | -1.45 | -1.03 | -0.04 |
| Net Income to Common | -6.95 | -6.95 | -1.45 | -1.03 | -0.04 |
| Shares Outstanding (Basic) | 139 | 139 | 260 | - | - |
| Shares Outstanding (Diluted) | 139 | 139 | 260 | - | - |
| Shares Change (YoY) | -46.36% | -46.36% | - | - | - |
| EPS (Basic) | -0.05 | -0.05 | -0.01 | - | - |
| EPS (Diluted) | -0.05 | -0.05 | -0.01 | - | - |
| Free Cash Flow | -5.09 | -5.09 | -1.54 | -0.57 | -0.03 |
| Free Cash Flow Per Share | -0.04 | -0.04 | -0.01 | - | - |
| Gross Margin | 100.00% | 100.00% | - | 100.00% | - |
| Operating Margin | -14162.28% | -14162.28% | - | -11195.03% | - |
| Profit Margin | -14192.25% | -14192.25% | - | -11314.40% | - |
| Free Cash Flow Margin | -10396.58% | -10396.58% | - | -6258.86% | - |
| EBIT | -6.94 | -6.94 | -1.44 | -1.02 | -0.03 |
| Advertising Expenses | - | - | - | 0 | 0.01 |
Source: S&P Capital IQ. Standard template.
Financial Sources.